# Randomized Teriparatide \[Human Parathyroid Hormone (PTH) 1–34\] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-teriparatide-human-parathyroid-hormone-pth-1-34-once-weekly-efficacy/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Toshitaka Nakamura,Toshitsugu Sugimoto,Tetsuo Nakano,Hideaki Kishimoto,Masako Ito,Masao Fukunaga,Hiroshi Hagino,Teruki Sone,Hideki Yoshikawa,Yoshiki Nishizawà,Takuo Fujita,Masataka Shiraki |
| Citations | 265 |
| DOI | 10.1210/jc.2011-3479 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/jcem/article-pdf/97/9/3097/9047302/jcem3097.pdf |
| OpenAlex ID | https://openalex.org/W1991819568 |
| PMID | 22723322 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Hideki Yoshikawa](https://scholariq.org/researchers/hideki-yoshikawa/)

## Paper journal

- [The Journal of Clinical Endocrinology & Metabolism](https://scholariq.org/journals/the-journal-of-clinical-endocrinology-and-metabolism/)

## Paper primary topic

- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)

## Paper topics

- [Bone health and osteoporosis research](https://scholariq.org/topics/bone-health-and-osteoporosis-research/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Bone Metabolism and Diseases](https://scholariq.org/topics/bone-metabolism-and-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.